Total planned funding: $183,126,931
Clear active filters
U.S. Centers for Disease Control and Prevention
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $17,323,723 |
Ethiopia | $15,882,870 |
Nigeria | $15,383,536 |
Uganda | $15,370,039 |
Mozambique | $12,240,360 |
South Africa | $11,229,926 |
Tanzania | $11,180,758 |
Botswana | $10,247,237 |
Côte d'Ivoire | $9,492,721 |
Vietnam | $8,727,935 |
Namibia | $8,273,971 |
Zambia | $8,107,000 |
Rwanda | $5,551,244 |
Zimbabwe | $4,955,000 |
Haiti | $4,820,500 |
Malawi | $2,787,000 |
Dominican Republic | $2,779,000 |
India | $2,721,168 |
Thailand | $2,597,880 |
Guyana | $2,106,315 |
Angola | $2,100,000 |
Cambodia | $1,918,835 |
Democratic Republic of the Congo | $1,717,655 |
South Sudan | $1,296,520 |
Ghana | $1,039,413 |
Eswatini | $989,928 |
Russia | $760,000 |
Lesotho | $705,000 |
China | $480,000 |
Cameroon | $341,397 |
Organizational Types
Own Agency | $174,252,552 |
Implementing Agency | $8,874,379 |
Program Areas
Management and Operations | $91,773,135 |
Governance and Systems | $57,724,733 |
Prevention | $12,034,982 |
Care | $10,484,087 |
Treatment | $7,940,130 |
Testing | $3,144,864 |
Budget Codes
HVMS: Management and Operations | $91,773,135 |
HVSI: Strategic Information | $31,564,722 |
HLAB: Laboratory Infrastructure | $15,011,793 |
OHSS: Health Systems Strengthening | $11,148,218 |
HTXS: Treatment: Adult Treatment | $6,286,192 |
HVTB: Care: TB/HIV | $5,465,432 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,984,309 |
HVOP: Sexual Prevention: Other Sexual Prevention | $3,751,591 |
HBHC: Care: Adult Care and Support | $3,736,861 |
HVCT: Testing: HIV Testing and Counseling | $3,144,864 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,816,847 |
HMBL: Biomedical Prevention: Blood Safety | $1,247,535 |
PDTX: Treatment: Pediatric Treatment | $1,210,416 |
PDCS: Care: Pediatric Care and Support | $878,606 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $507,813 |
HTXD: Treatment: ARV Drugs | $443,522 |
HKID: Care: Orphans and Vulnerable Children | $403,188 |
HMIN: Biomedical Prevention: Injection Safety | $369,852 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $357,035 |